Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | SVP - Corporate Business Dev | November 03, 2020 | November 05, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date November 03, 2020 · Filed November 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,447 |
Reported balance
After 2020-11-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-03 · Exercise / conversion · Acquired 4,775 · Balance 13,447 |
| Common StockSEC Table I · non-derivative | Direct | 17,949 |
Reported balance
After 2020-11-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-11-03 · Exercise / conversion · Acquired 4,502 · Balance 17,949 |
| Common StockSEC Table I · non-derivative | Direct | 21,383 |
Reported balance
After 2020-11-03 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2020-11-03 · Exercise / conversion · Acquired 3,434 · Balance 21,383 |
| Common StockSEC Table I · non-derivative | Direct | 24,463 |
Reported balance
After 2020-11-03 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2020-11-03 · Exercise / conversion · Acquired 3,080 · Balance 24,463 |
| Common StockSEC Table I · non-derivative | Direct | 9,349 |
Reported balance
After 2020-11-03 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2020-11-03 · Sale · Disposed 15,114 · Balance 9,349 F1: This transaction was executed in multiple trades at prices ranging from $212.33 to $212.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2: Includes 68 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $135.57 · Expires 2027-09-12 | Direct | 4,503 |
Reported balance
After 2020-11-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-03 · Exercise / conversion · Disposed 4,502 · Balance 4,503 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $123.09 · Expires 2026-09-13 | Direct | 0 |
Reported balance
After 2020-11-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-11-03 · Exercise / conversion · Disposed 4,775 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $155.54 · Expires 2029-09-17 | Direct | 10,303 |
Reported balance
After 2020-11-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-11-03 · Exercise / conversion · Disposed 3,434 · Balance 10,303 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $151.85 · Expires 2028-09-18 | Direct | 6,160 |
Reported balance
After 2020-11-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-11-03 · Exercise / conversion · Disposed 3,080 · Balance 6,160 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $212.33 to $212.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Includes 68 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,080 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · derivative · entry 9 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 3,080 shares Expires 2028-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,434 | $0.00 Strike: $155.54 | $0.00 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · derivative · entry 8 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,303 Underlying: Common Stock · 3,434 shares Expires 2029-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,775 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · derivative · entry 7 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,775 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,502 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · derivative · entry 6 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,503 Underlying: Common Stock · 4,502 shares Expires 2027-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 15,114 | $212.47 | $3,211,262.51 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · nonDerivative · entry 5 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,349 F1 · price: This transaction was executed in multiple trades at prices ranging from $212.33 to $212.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 68 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 3,080 | $151.85 | $467,698.00 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · nonDerivative · entry 4 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 3,434 | $155.54 | $534,124.36 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · nonDerivative · entry 3 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 4,502 | $135.57 | $610,336.14 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · nonDerivative · entry 2 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 4,775 | $123.09 | $587,754.75 |
DisclosureSEC source: 0001225208-20-013141 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 1,299 | $228.30 | $296,561.70 |
DisclosureSEC source: 0001225208-20-010953 · doc4.xml · nonDerivative · entry 2 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,604 F2 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,618 | $228.30 | $597,689.40 |
DisclosureSEC source: 0001225208-20-010953 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,903 F1 · kind: Settlement of 2017 Performance Unit Grant that vested 8/20/2020. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 20:59 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 634 | $224.25 | $142,174.50 |
DisclosureSEC source: 0001225208-20-010703 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,285 F1 · kind: Withholding of shares by the Company to satisfy certain tax obligations applicable to the payout of Common Stock underlying settlement of 2016 Performance Unit Grant that vested on 8/16/2018, which the reporting person had elected to defer pursuant to the 2005 Stock Incentive Plan. F2 · balance_after: Includes 99 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,080 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · derivative · entry 5 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,240 Underlying: Common Stock · 3,080 shares Expires 2028-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,005 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · derivative · entry 4 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,005 Underlying: Common Stock · 9,005 shares Expires 2027-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 11,468 | $238.50 | $2,735,118.00 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · nonDerivative · entry 3 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,820 Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 3,080 | $151.85 | $467,698.00 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · nonDerivative · entry 2 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 9,005 | $135.57 | $1,220,807.85 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:01 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,325 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-20-007595 · doc4.xml · derivative · entry 3 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,775 Underlying: Common Stock · 9,325 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:01 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 7,969 | $207.53 | $1,653,820.12 |
DisclosureSEC source: 0001225208-20-007595 · doc4.xml · nonDerivative · entry 2 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,203 F1 · price: This transaction was executed in multiple trades at prices ranging from $207.51 to $207.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 98 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:01 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 9,325 | $123.09 | $1,147,814.25 |
DisclosureSEC source: 0001225208-20-007595 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 23:38 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 13,737 | $0.00 Strike: $155.54 | $0.00 |
DisclosureSEC source: 0001225208-19-012724 · doc4.xml · derivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,737 Underlying: Common Stock · 13,737 shares Expires 2029-09-17 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 21:57 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 767 | $159.15 | $122,068.05 |
DisclosureSEC source: 0001225208-19-011882 · doc4.xml · nonDerivative · entry 2 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,749 Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 21:57 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,215 | $159.15 | $352,517.25 |
DisclosureSEC source: 0001225208-19-011882 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,516 F1 · kind: Settlement of 2016 Performance Unit Grant that vested 8/22/2019. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 21:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-19-009131 · doc4.xml · derivative · entry 3 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,100 Underlying: Common Stock · 5,000 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 21:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 4,582 | $159.14 | $729,160.24 |
DisclosureSEC source: 0001225208-19-009131 · doc4.xml · nonDerivative · entry 2 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,301 F1 · price: This transaction was executed in multiple trades at prices ranging from $159.12 to $159.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 165 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 21:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 5,000 | $123.09 | $615,450.00 |
DisclosureSEC source: 0001225208-19-009131 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 22:02 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 12,320 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-18-013637 · doc4.xml · derivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,320 Underlying: Common Stock · 12,320 shares Expires 2028-09-18 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:50 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 62 | $146.77 | $9,099.74 |
DisclosureSEC source: 0001225208-18-012773 · doc4.xml · nonDerivative · entry 2 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 F2 · kind: Withholding of stock to pay certain taxes under the Company's Stock Withholding Arrangement. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:50 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,700 | $146.77 | $396,279.00 |
DisclosureSEC source: 0001225208-18-012773 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,780 F1 · kind: Settlement of 2015 Performance Unit Grant that vested 8/16/2018, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 21:24 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 220 | $141.99 | $31,237.80 |
DisclosureSEC source: 0001225208-18-001014 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,080 F1 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. F2 · balance_after: Includes 12 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:25 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 18,010 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-17-015013 · doc4.xml · derivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,010 Underlying: Common Stock · 18,010 shares Expires 2027-09-12 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 21:15 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 219 | $118.72 | $25,999.68 |
DisclosureSEC source: 0001225208-17-001106 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,288 F1 · kind: Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock. F2 · balance_after: Includes 7 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 21:03 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 19,100 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-16-039407 · doc4.xml · derivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,100 Underlying: Common Stock · 19,100 shares Expires 2026-09-13 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.